A termék adatai:
| ISBN13: | 9780443224201 |
| ISBN10: | 044322420X |
| Kötéstípus: | Keménykötés |
| Terjedelem: | 300 oldal |
| Méret: | 228x152 mm |
| Nyelv: | angol |
| 700 |
Témakör:
CRISPR-Cas-Based Genome Editing for Treating Human Diseases - Part B
Sorozatcím:
Progress in Molecular Biology and Translational Science;
210;
Kiadó: Academic Press
Megjelenés dátuma: 2025. január 1.
Normál ár:
Kiadói listaár:
EUR 122.00
EUR 122.00
Az Ön ára:
46 808 (44 579 Ft + 5% áfa )
Kedvezmény(ek): 10% (kb. 5 201 Ft)
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
Kattintson ide a feliratkozáshoz
Beszerezhetőség:
Még nem jelent meg, de rendelhető. A megjelenéstől számított néhány héten belül megérkezik.
Hosszú leírás:
CRISPR-Cas-Based Genome Editing for Treating Human Diseases, Part B represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems have been proven to be a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. Chapters in this release include Current approaches in CRISPR -Cas systems for metabolic disorders, Recent progress in CRISPR -Cas systems for CRISPR for retinal diseases, Recent progress in CRISPR -Cas systems for cataract and blindness, Advances in CRISPR -Cas systems for muscular dystrophy, Recent development in CRISPR -Cas systems for cardiac disease, Current approaches in CRISPR -Cas systems for diabetes, and much more.
Additional sections cover Advances in CRISPR -Cas systems for liver disease, Advances in CRISPR -Cas systems for lung disease, Advances in CRISPR -Cas systems for kidney diseases, Current progress in CRISPR -Cas systems for rare disease, Advances in CRISPR -Cas systems for heredity disease, Recent progress in CRISPR -Cas systems for neurological disorders, and CRISPR challenges in clinical developments.
Additional sections cover Advances in CRISPR -Cas systems for liver disease, Advances in CRISPR -Cas systems for lung disease, Advances in CRISPR -Cas systems for kidney diseases, Current progress in CRISPR -Cas systems for rare disease, Advances in CRISPR -Cas systems for heredity disease, Recent progress in CRISPR -Cas systems for neurological disorders, and CRISPR challenges in clinical developments.
Tartalomjegyzék:
Preface
Vijai Singh
1. Current approaches in CRISPR -Cas systems for metabolic disorders
DHRUV KUMAR
2. Recent progress in CRISPR -Cas systems for CRISPR for retinal diseases
Mayank Bansal
3. Recent progress in CRISPR -Cas systems for cataract and blindness
Suresh Ramakrishna
4. Advances in CRISPR -Cas systems for muscular dystrophy
Vancha Harish
5. Recent development in CRISPR -Cas systems for cardiac disease
Xin Wang
6. Current approaches in CRISPR -Cas systems for diabetes
L. Karthik
7. Advances in CRISPR -Cas systems for liver disease
Majid Mojarrad
8. Advances in CRISPR -Cas systems for lung disease
Suresh Ramakrishna
9. Advances in CRISPR -Cas systems for kidney diseases
Anil Bhanudas Gaikwad
10. Current progress in CRISPR -Cas systems for rare disease
Ajay Kumar I
11. Advances in CRISPR -Cas systems for heredity disease
DHRUV KUMAR
12. Recent progress in CRISPR -Cas systems for neurological disorders
Anand Krishna Tiwari
13. CRISPR challenges in clinical developments
Hossein Soltaninejad, Mohadeseh Khoshandam and Saman Hosseinkhani
Vijai Singh
1. Current approaches in CRISPR -Cas systems for metabolic disorders
DHRUV KUMAR
2. Recent progress in CRISPR -Cas systems for CRISPR for retinal diseases
Mayank Bansal
3. Recent progress in CRISPR -Cas systems for cataract and blindness
Suresh Ramakrishna
4. Advances in CRISPR -Cas systems for muscular dystrophy
Vancha Harish
5. Recent development in CRISPR -Cas systems for cardiac disease
Xin Wang
6. Current approaches in CRISPR -Cas systems for diabetes
L. Karthik
7. Advances in CRISPR -Cas systems for liver disease
Majid Mojarrad
8. Advances in CRISPR -Cas systems for lung disease
Suresh Ramakrishna
9. Advances in CRISPR -Cas systems for kidney diseases
Anil Bhanudas Gaikwad
10. Current progress in CRISPR -Cas systems for rare disease
Ajay Kumar I
11. Advances in CRISPR -Cas systems for heredity disease
DHRUV KUMAR
12. Recent progress in CRISPR -Cas systems for neurological disorders
Anand Krishna Tiwari
13. CRISPR challenges in clinical developments
Hossein Soltaninejad, Mohadeseh Khoshandam and Saman Hosseinkhani